The Lexie B2 Plus is a mid-priced OTC hearing aid that earned an A grade in HearAdvisor lab testing, placing it in the top 5% of all OTC devices tested. At $999, this behind-the-ear device has received Expert's Choice recognition in both 2023 and 2024, reflecting its consistently strong performance.
In our testing, the B2 Plus demonstrated exceptional speech clarity in quiet environments, scoring 1.68 points above the category average. Speech understanding in noisy situations also measured above average, though the margin was more modest at 0.80 points above typical OTC performance. Where this device truly excels is own-voice comfort—scoring 2.29 points above average—making it particularly appealing for users sensitive to the hollow or boomy sound of their own voice that can occur with hearing aids.
The B2 Plus does show limitations in certain areas. Feedback handling measured 1.70 points below the category average, and music streaming quality fell 0.84 points below average. Users who prioritize audio streaming or encounter frequent feedback issues may want to consider alternatives like the Sony CRE-E10, which leads the price category with a perfect 5.0 score.
This device is well-suited for first-time OTC hearing aid users who prioritize natural speech understanding and own-voice comfort over streaming features. The rechargeable batteries and compatibility with both iPhone and Android devices add practical convenience. For budget-conscious shoppers, the Yeasound RIC700 offers similar sound performance at $599, though with a somewhat lower overall score.
